Dáil Éireann Debate, Wednesday - 18 September 2024
701. Deputy Pádraig O'Sullivan asked the Minister for Health if the HSE will consider the reimbursement of ibrutinib plus venetoclax for patients with chronic lymphocytic leukaemia; and if he will make a statement on the matter. [36428/24]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
